Novel Treatments Paradigms: Membranous Nephropathy.
Ontology highlight
ABSTRACT: Primary membranous nephropathy (MN) is a kidney-specific autoimmune glomerular disease and the leading cause of nephrotic syndrome (NS) in White adults, usually caused by antiphospholipase A2 receptor (PLA2R) antibodies, although several new target antigens have been recently identified. It is characterized by the diffuse thickening of the glomerular basement membrane secondary to immune complex deposition. In patients with persistent NS without response to maximizing conservative therapy including the use of renin-angiotensin system (RAS) blockers, the use of immunosuppressive agents is warranted. However, the optimal immunosuppressive treatment has not yet been established. Classical immunosuppressants, such as cyclophosphamide plus steroids, are effective but may cause clinically releva
SUBMITTER: Rojas-Rivera JE
PROVIDER: S-EPMC10014375 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA